Search Results - "Savinkova, A V"

INHIBITION OF REDD1 EXPRESSION FOR THE REDUCTION OF GLUCOCORTICOID-INDUCED SIDE EFFECTS by Lylova, E. S., Savinkova, A. V., Zhidkova, E. M., Kirsanov, K. I., Yakubovskaya, M. G., Budunova, I. V., Lesovaya, E. A.

“…Glucocorticoids (GC ) have been an integral component of the treatment of leukemias and lymphomas for several decades. Specific cytotoxic effect of GC on…”
Get full text

COMPARATIVE ANALYSIS OF BIOLOGICAL EFFECTS OF SELECTIVE ACTIVATOR OF THE GLUCOCORTICOID RECEPTOR CPDA ON DIFFERENT SUBTYPES OF BREAST CANCER CELL LINES by Zhidkova, E. M., Kuzin, K. A., Tilova, L. R., Savinkova, A. V., Borisova, O. I., Lavrova, M. D., Maximova, V. P., Kirsanov, K. I., Yakubovskaya, M. G., Lesovaya, E. A.

“…Glucocorticoids (GCs) are often used as an adjuvant therapy to reduce the adverse effects of chemotherapy in breast cancer patients. Moreover, GCs can display…”
Get full text

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT by Savinkova, A. V., Zhidkova, E. M., Tilova, L. R., Lavrova, M. D., Lylova, E. S., Kuzin, K. A., Portyannikova, A. Yu, Maximova, V. P., Kholodova, A. V., Vlasova, O. A., Fetisov, T. I., Kirsanov, K. I., Belitskiy, G. A., Yakubovskaya, M. G., Lesovaya, E. A.

“…Recently many new approaches for repurposing or repositioning of the clinically used drugs have been developed. Drug repurposing  allows not only to use known…”
Get full text

Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-nave prostate cancer by Matveev, V B, Kirichek, A A, Filippova, M G, Savinkova, A V, Khalmurzaev, O A, Lyubchenko, L N

“…as shown in previous studies, mutations in the BRCA1/2 and CHEK2 genes are associated with worsened long-term results of the definitive treatment for localized…”
Get more information